Novo Nordisk's semaglutide, which could be the first oral ... "Delivering protein-based medicine like semaglutide in the form of a tablet and producing it on a large scale is a major challenge ...

Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...

Novo Nordisk is providing direct-to-patient delivery of Wegovy (semaglutide) through the NovoCare Pharmacy program.

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

The cost of compounded versions of semaglutide sold by online telehealth providers ranged from $150 to $280 for a month’s supply. “Novo Nordisk continues to advance solutions for patients that ...

Novo Nordisk is taking a page out of Eli Lilly’s playbook as the two GLP-1 drugmakers work to fend off compounding pharmacies ...

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

At $28.4 billion in sales last year, Novo Nordisk's semaglutide is still the market leader. Unfortunately, semaglutide sales rose just 35% last year. Now that Surmount-5 trial results are in the ...

Novo Nordisk released the results from its late-stage trial of CagriSema on Monday. It showed that patients on the highest dose of the drug lost 15.7% of their weight.

For eligible patients, health care providers can send Wegovy prescriptions directly to NovoCare Pharmacy. Novo Nordisk is providing direct-to-patient delivery of Wegovy ® (semaglutide) through ...

(That's a name to remember. Similar to Novo Nordisk's semaglutide and Eli Lilly's tirzepatide, petrelintide mimics a naturally occurring hormone, causing patients to feel full so that they eat ...